GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective treatment options for obesity
EH8965 Size 48T/96T Species Human UniProt ID P09488 Sample Type Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples Detection Method Sandwich ELISA, Double Antibody Detection Wavelength OD450 Reaction Duration 4 hours Range 0.313-20ng/ml Sensitivity 0.188ng/ml Storage 2-8C(Sealed), Don't cryopreserve
Be picky about fats Limit fats from processed meats, like bacon and sausages, which are rich in saturated fats and trans fats, that are associated with chronic disease
Although the SAVOR and EXAMINE studies were delineated to verify cardiovascular safety of two DPP-4i, namely saxagliptin and alogliptin, respectively, both are considered to be the first controlled clinical trials to address the effect of GLP-1 system on CVD